capital injection required to take over the closed book of traditional life business. Moreover, the Company entered into an agreement with a Belgian Insurance company for a life corporate insurance book transaction. This transaction is envisaged to
with a Belgian Insurance company for a life insurance book transaction. This transaction is envisaged to complete over the course of Q3 2023, after regulatory approval. In line with the growth of the Company, the Company has to continue to strengthen
Integrale SA with the associated capital injections to back them. Moreover, the Company entered into an agreement with AXA Belgium NV for the AXA Portfolio. This transaction is envisaged to complete over the course of September 2022. Over the course of
Améliorez votre expérience de navigation grâce à nos cookies
Nous utilisons des cookies pour vous offrir la meilleure expérience sur notre site. Vous pouvez en savoir plus sur les cookies que nous utilisons ou les désactiver dans les paramètres de cookies.